BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35400336)

  • 1. Identification of Immune Infiltration and Prognostic Biomarkers in Small Cell Lung Cancer Based on Bioinformatic Methods from 3 Studies.
    Cao J; Yu C
    Comb Chem High Throughput Screen; 2023; 26(3):507-516. PubMed ID: 35400336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Six Novel Prognostic Gene Signatures as Potential Biomarkers in Small Cell Lung Cancer.
    Feng S; Zhang X; Gu X; Zhou M; Chen Y; Wang C
    Comb Chem High Throughput Screen; 2023; 26(5):938-949. PubMed ID: 35490316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Common and distinct features of potentially predictive biomarkers in small cell lung carcinoma and large cell neuroendocrine carcinoma of the lung by systematic and integrated analysis.
    Dong S; Liang J; Zhai W; Yu Z
    Mol Genet Genomic Med; 2020 Mar; 8(3):e1126. PubMed ID: 31981472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Key Biomarkers and Pathways in Small-Cell Lung Cancer Using Biological Analysis.
    Liu H; Li T; Ye X; Lyu J
    Biomed Res Int; 2021; 2021():5953386. PubMed ID: 34712733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
    Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
    Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic biomarkers and immune cell infiltration characteristics in small cell lung cancer.
    Ni J; Si X; Wang H; Zhang X; Zhang L
    Cancer Pathog Ther; 2023 Jan; 1(1):18-24. PubMed ID: 38328611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. POLE2 Serves as a Prognostic Biomarker and Is Associated with Immune Infiltration in Squamous Cell Lung Cancer.
    Wu Z; Wang YM; Dai Y; Chen LA
    Med Sci Monit; 2020 Apr; 26():e921430. PubMed ID: 32304567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive Bioinformatics Analysis Identifies Tumor Microenvironment and Immune-related Genes in Small Cell Lung Cancer.
    Song Y; Sun Y; Sun T; Tang R
    Comb Chem High Throughput Screen; 2020; 23(5):381-391. PubMed ID: 32264809
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of key genes and biological pathways in Chinese lung cancer population using bioinformatics analysis.
    Liu P; Li H; Liao C; Tang Y; Li M; Wang Z; Wu Q; Zhou Y
    PeerJ; 2022; 10():e12731. PubMed ID: 35178291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comprehensive Bioinformatic Analysis for Identification of Myeloid-Associated Differentiation Marker as a Potential Negative Prognostic Biomarker in Non-Small-Cell Lung Cancer.
    Zhou M; Chen Y; Gu X; Wang C
    Pathol Oncol Res; 2022; 28():1610504. PubMed ID: 36061144
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods.
    Li X; Gao Y; Xu Z; Zhang Z; Zheng Y; Qi F
    Cancer Med; 2020 Feb; 9(3):1161-1172. PubMed ID: 31856409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and Integrate Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer Based on Bioinformatics Analysis.
    Gong K; Zhou H; Liu H; Xie T; Luo Y; Guo H; Chen J; Tan Z; Yang Y; Xie L
    Technol Cancer Res Treat; 2021; 20():15330338211060202. PubMed ID: 34825846
    [No Abstract]   [Full Text] [Related]  

  • 14. Construction of Prognostic Risk Model for Small Cell Lung Cancer Based on Immune-Related Genes.
    Deng F; Tao F; Xu Z; Zhou J; Gong X; Zhang R
    Comput Math Methods Med; 2022; 2022():7116080. PubMed ID: 36245844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of prognostic genes in the pancreatic adenocarcinoma immune microenvironment by integrated bioinformatics analysis.
    Wang H; Lu L; Liang X; Chen Y
    Cancer Immunol Immunother; 2022 Jul; 71(7):1757-1769. PubMed ID: 34854950
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
    Liu X; Liu X; Li J; Ren F
    Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Network analysis of differentially expressed genes reveals key genes in small cell lung cancer.
    Tantai JC; Pan XF; Zhao H
    Eur Rev Med Pharmacol Sci; 2015 Apr; 19(8):1364-72. PubMed ID: 25967710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of prognostic immune-related gene signature associated with tumor microenvironment of colorectal cancer.
    Wang Y; Li W; Jin X; Jiang X; Guo S; Xu F; Su X; Wang G; Zhao Z; Gu X
    BMC Cancer; 2021 Aug; 21(1):905. PubMed ID: 34364366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The identification of hub biomarkers and pathways in lung cancer and prognostic evaluation.
    Yin Y; Li D; He M; Wang J
    Transl Cancer Res; 2022 Aug; 11(8):2622-2635. PubMed ID: 36093542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of significant genes as prognostic markers and potential tumor suppressors in lung adenocarcinoma via bioinformatical analysis.
    Lu M; Fan X; Liao W; Li Y; Ma L; Yuan M; Gu R; Wei Z; Wang C; Zhang H
    BMC Cancer; 2021 May; 21(1):616. PubMed ID: 34039311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.